side effects of glp-1 medications Your guide to The GLP-1 Agonists and Obesity:

Realistic expectations: 5-10 pounds lean muscle (drug-free this would take 1-2 years) Body fat reduced 2-4% Strength up 20-30% Overall appearance transformed Month 6-12: Peak results and beyond Physical changes: 8-15 pounds lean muscle (cumulative, depends heavily on starting point) Strength plateaus at new higher baseline Body composition optimized Continued slow improvements What you'll notice: You've reached a new baseline Further gains slow down but you maintain easily The "enhanced" look is permanent if you continue basic protocol Can reduce peptide frequency to maintenance doses What photos show: Maximum transformation

Key Features Defined 15-Amino Acid Sequence What it is: The exact chain of Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val

Expected population level mortality impacts by age under the central scenario

Additionally, in another Phase II study targeting patients with T2DM, orforglipron also showed significant effects in reducing A1C and weight, achieving the studys primary and secondary endpoints

In 2015, Aly et al

24 Based on these findings, two GLP-1 RAs were approved by the US FDA to treat obesity so far: liraglutide and semaglutide